These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significance of serum tumor markers in patients with carcinoma of the ovary. Kikuchi Y, Kizawa I, Koyama E, Kato K. Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705 [Abstract] [Full Text] [Related]
9. Placental protein 4 as a possible tumor marker in ovarian tumors. Göcze PM, Szabò DG, Than GN, Krommer KF, Csaba IF, Bohn H. Gynecol Obstet Invest; 1991 Jul; 32(2):107-11. PubMed ID: 1836196 [Abstract] [Full Text] [Related]
10. [Placental protein 5 and pregnancy zone protein in ovarian cysts and benign cystic ovarian tumors]. Briese V, Than G, Richter D, Iino K, Seppälä M. Zentralbl Gynakol; 1988 Jul; 110(13):821-3. PubMed ID: 3176735 [Abstract] [Full Text] [Related]
15. Enzyme immunoassay for placental protein 4 (PP4) and its possible diagnostic significance in patients with genital tract cancer. Ota Y, Inaba N, Shirotake S, Fukazawa I, Takamizawa H, Bohn H. Arch Gynecol Obstet; 1990 Jul; 247(3):139-47. PubMed ID: 2142405 [Abstract] [Full Text] [Related]
16. Cytotoxic effects of leukocytes and plasma on primary cultures of ovarian carcinoma. Halbrecht I, Komlos L. Obstet Gynecol; 1974 Feb; 43(2):268-75. PubMed ID: 4810236 [No Abstract] [Full Text] [Related]
17. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production. Higuchi Y, Kouno T, Teshima H, Akizuki S, Kikuta M, Ohyumi M, Yamamoto S. Arch Pathol Lab Med; 1984 Sep; 108(9):710-2. PubMed ID: 6205636 [Abstract] [Full Text] [Related]